SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-20-000080
Filing Date
2020-07-27
Accepted
2020-07-27 17:27:45
Documents
2
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159588525290974.html 4  
1 FORM 4 wf-form4_159588525290974.xml 4 3330
2 POA - MCELHAUGH poa-mcelhaugh.htm EX-24 3343
  Complete submission text file 0001447028-20-000080.txt   8223
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
McElhaugh Michael J. (Reporting) CIK: 0001635326 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 201051192